To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
A house committee must act next: committee consideration.
Govbase has not yet run an impact analysis on this legislation.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Analysis generated by AI. Always verify with official sources.